bromocriptine has been researched along with Endocrine Gland Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Herder, WW; Hofland, LJ; Kros, MJ; Lamberts, SW; Uitterlinden, P; Van Koetsveld, PM; Van Uffelen, C; Visser-Wisselaar, HA; Waaijers, M; Zuyderwijk, J | 1 |
1 other study(ies) available for bromocriptine and Endocrine Gland Neoplasms
Article | Year |
---|---|
Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
Topics: Adenoma; Adenoma, Islet Cell; Aminoquinolines; Bromocriptine; Dopamine Agonists; Endocrine Gland Neoplasms; Hormone Antagonists; Hormones; Humans; Insulinoma; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactinoma; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured | 1997 |